The investigational drug, first developed for brain cancer, is being tested to see whether it can make resistant tumors respond to treatment again.
Dr. John Friend
Advertisement
Articles by Dr. John Friend
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
The Growing Role of AI in Cancer Care
2
Blood Cancer Treatments in the FDA Pipeline: What Could Come Next
3
Why Some Stage 3 Lung Cancers Don't Respond to Treatment, and What Researchers Are Trying Next
4
3 More Lung Cancer Breakthroughs From WCLC 2026
5